Digital Therapeutics a $56billion globally opportunity by 2025!*
The unprecedented growth of the Digital Therapeutic Market (DTx) has been one of the key highlights of recent years.
Today we share a quick overview of the 3 key DTx trends we’ll be seeing in the near future:
- Rising interest in DTx
COVID-19 served as an accelerator of the digitalisation of healthcare. Increasing number of patients and KOLs seek innovative treatment options, such as DTx.
- Development of clear reimbursement pathways
Germany is the first country to have implemented a P&R pathway specific to DTx. NICE regularly update their Evidence Standards Framework for Digital Health Technologies. The rest of the EU5 countries are likely to develop such pathways in the future.
- Increasing reimbursement rates of DTx
The adoption of specific regulatory and P&R pathways to DTx is likely to translate into more DTx being reimbursed.
* source: 2020 Digital Therapeutics Report by Insider Intelligence